Home    Back

Dutasteride    (DrugBank: Dutasteride)

2 diseases
IDDisease name (Link within this page)Number of trials
1Spinal and bulbar muscular atrophy1
2Amyotrophic lateral sclerosis1

1. Spinal and bulbar muscular atrophy    [ 17 clinical trials,   16 drugs,   (DrugBank: 8 drugs),   10 drug target genes,   15 drug target pathways]
Searched query = "Spinal and bulbar muscular atrophy", "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 17 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00303446
(ClinicalTrials.gov)		March 200615/3/2006Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients With Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)Kennedy's Disease;Spinal and Bulbar Muscular AtrophyDrug: Dutasteride;Drug: PlaceboNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompleted18 YearsN/AMale57Phase 2United States

2. Amyotrophic lateral sclerosis    [ 508 clinical trials,   530 drugs,   (DrugBank: 146 drugs),   170 drug target genes,   221 drug target pathways]
Searched query = "Amyotrophic lateral sclerosis", "ALS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 508 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04654689
(ClinicalTrials.gov)		January 202113/11/2020Impact of the Combined Treatment of Liposomed Polyphenols With Dutasteride on the ALS PatientsImpact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With Dutasteride on the Clinical Improvement of ALS PatientsAmyotrophic Lateral SclerosisDietary Supplement: Liposomed polyphenols resveratrol and curcumin;Other: Placebo for liposomed resveratrol and curcumin;Dietary Supplement: Isocaloric Diet;Drug: Dutasteride 0.5 mg;Other: Placebo microcrystalline methylcelluloseFundación Universidad Católica de Valencia San Vicente MártirNULLNot yet recruiting18 Years75 YearsAll100Phase 2Spain